Articles

• What is the Best Treatment for Macular Edema?

  By Robert L. Avery MD; and Allen C. Ho, MD

• Medical Update

  By Section Editor: David Boyer, MD

• Reflecting Back on Fellowship

  Two newly minted attendings provide perspective on how their fellowship training has prepared them for practice.

  By Michael M. Lai, MD, PhD; and Peter Ho Win, MD

• Thinking About Building a Retina ASC?

  The future is at hand—let's get started.

  By Glenn A. deBrueys

• Repair of Primary Rhegmatogenous Retinal Detachment

  Choose the surgery that fits the detachment and the patient.

  By Karen M. Gehrs, MD

• Microincision Vitrectomy Surgery in Japan

  By Yusuke Oshima, MD, PhD

• Müller Cells as Players in Retinal Edema

  Triamcinolone may stimulate fluid absorption from the retinal tissue.

  By Andreas Bringmann, MD

• Treatment of Uveitic Cystoid Macular Edema

  Three case reports discuss the management of inflammatory CME.

  By Pranjal Thakuria, MD; and C. Stephen Foster, MD

• ILM Peeling for Macular Edema Secondary to BRVO

  Triamcinolone acetonide assists 25-gauge vitrectomy and ILM peeling for this indication.

  By Jin Ma, MD

• IVTA for Macular Edema Secondary to BRVO

  Central macular thickness was reduced with IVTA injection, but eyes with previous laser photocoagulation had less benefit.

  By Mehmet Cakir, MD

• The Role of VEGF in Macular Edema for Patients With RVO

  Ranibizumab provides substantial short-term benefit.

  By Peter A. Campochiaro, MD

• CME from the Anterior Segment Surgeon's Perspective

  What the posterior segment specialist should know.

  By Eric D. Donnenfeld, MD

• Thermoresponsive Hydrogels for Posterior Segment Drug Delivery

  These materials appear to be promising for sustained release of drugs, including anti-VEGF agents, to the posterior segment.

  By Jennifer J. Kang Derwent, PhD; and William F. Mieler, MD

• Systemic Risk Factors Associated With Visual Outcomes in Young Patients With RVO

  Retinal vein occlusions in younger patients are strongly associated with systemic risk factors.

  By Michael M. Lai, MD, PhD

• Managing the New Logistics of Retinal Therapy

  In an ongoing series, a practitioner explains how his multi-office practice manages the increase patient volume brought on by intravitreal injections.

  By Jay S. Pepose, MD, PhD; and Gitane Patel, MD, MPH

• Managing the New Logistics of Retinal Therapy

  In an ongoing series, a practitioner explains how his multi-office practice manages the increase patient volume brought on by intravitreal injections.

  By Mitchell S. Fineman, MD

• How to Motivate Your Diabetes Patients to be Physically Active

  Providing education and motivation encouraging patients to make lifestyle changes is not as straightforward as it should be, and attempts often result in failure.

  By Sheri R. Colberg, PhD, FACSM

• CONFERENCE CALENDAR

• 5 Questions with J. Fernando Arevalo, MD, FACS

  Dr. Arevalo is Director of Ophthalmology at the Clinica Oftalmologica Centro Caracas in Caracas, Venezuela, and Immediate Past-President of the Pan-American Retina & Vitreous Society.

  By J. Fernando Arevalo, MD, FACS